RedHill Biopharma (RDHL) EBIT Margin (QoQ) (2012 - 2023)
RedHill Biopharma (RDHL) EBIT Margin (QoQ) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.38 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.87 Bn | 40.22 Bn | 2.15 Bn |
| 3 | Zoetis | 32.46 Bn | 30.78 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | RedHill Biopharma | 1.90 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 380,088.00 |
| Mar 31, 2023 | -21,619.00 |
| Dec 31, 2022 | -63,231.00 |
| Sep 30, 2022 | -943.00 |
| Jun 30, 2022 | -7,698.00 |
| Mar 31, 2022 | 76,833.00 |
| Dec 31, 2021 | -72,195.00 |
| Sep 30, 2021 | -3,523.00 |
| Jun 30, 2021 | 2,751.00 |
| Mar 31, 2021 | -361.00 |
| Dec 31, 2020 | 2,279.00 |
| Sep 30, 2020 | 923.00 |
| Jun 30, 2020 | -155,155.00 |
| Mar 31, 2020 | 87,149.00 |
| Dec 31, 2019 | 3,723.00 |
| Sep 30, 2019 | -8,943.00 |
| Jun 30, 2019 | 26,167.00 |
| Mar 31, 2019 | -20,860.00 |
| Dec 31, 2018 | 29,766.00 |
| Sep 30, 2018 | 3,466.00 |